We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Rapid Immunopurification Technique Enables Accurate Determination of Mitochondrial Metabolites

By LabMedica International staff writers
Posted on 14 Sep 2016
Print article
Image: A scanning electron micrograph (SEM) of two mitochondria from mammalian lung tissue displaying their matrix and membranes (Photo courtesy of Wikimedia Commons).
Image: A scanning electron micrograph (SEM) of two mitochondria from mammalian lung tissue displaying their matrix and membranes (Photo courtesy of Wikimedia Commons).
A rapid immunopurification technique was used to isolate mitochondria with metabolite contents that were relatively undamaged by enzyme activity and free from components of other cellular organelles.

While metabolite profiling by mass spectrometry has been widely applied for research purposes at the whole-cell level, it is not routinely possible to measure the concentrations of small molecules in mammalian organelles. However, in a recent development in this field, investigators at the Whitehead Institute (Cambridge, MA, USA) have developed a method for the rapid and specific isolation of mitochondria that allows accurate quantification of this organelle's metabolite content.

Up to now, various methods of differential centrifugation have been used to isolate mitochondria. Unfortunately, these protocols also precipitate non-mitochondrial material and other organelles. In addition, these relatively lengthy procedures promote enzymatic modifications of mitochondrial metabolites that lead to variable results.

The investigators described a novel immunopurification technique for isolation of mitochondria in the August 25, 2016, issue of the journal Cell. The method was based on antibody-covered beads that bound to specific mitochondrial surface markers. Recovery of antibody-bead-mitochondria complexes permitted rapid disruption of the mitochondria and inhibition of all enzymatic activity within 10 minutes. The immunopurification technique was used it in tandem with a database of predicted mitochondrial metabolites ("MITObolome") to measure the matrix concentrations of more than 100 metabolites across various states of mitochondrial respiratory chain (RC) function.

"The advantage of this new method is that it offers a combination of both increased speed and specificity," said senior author Dr. David Sabatini, professor of biology at the Whitehead Institute. "We are quite excited about applying this workflow in vivo and to other organelles such as lysosomes."

Related Links:
Whitehead Institute

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.